Treatment of pyoderma gangrenosum with the anti-TNFα drug - Etanercept

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 4, 2008, Pages 431-433

  Rogge, Fabrice J ^a   Pacifico, Mark ^a   Kang, Norbert ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Anti TNF ; Etanercept; Pyoderma gangrenosum; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ETANERCEPT; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADRENAL SUPPRESSION; ADULT; ARTICLE; CASE REPORT; CUSHING SYNDROME; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOOT ULCER; GENERAL PRACTITIONER; HUMAN; MALE; PATIENT REFERRAL; PLASTIC SURGERY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION SCHEDULE; FOOT ULCER; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40749086341     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2006.11.011     Document Type: Article

References (5)

1. Reichrath J., Bens G., Bonowitz A., et al. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53 (2005) 273-283
2. Trent J., and Kerdel F. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. Dermatol Nurs 17 (2005) 97-107
3. McGowan J.W., Johnson C.A., and Lynn A. Treatment of pyoderma gangrenosum with Etanercept. J Drugs Dermatol 3 (2004) 441-444
4. Niezgoda J.A., Cabigas E.B., Allen H.K., et al. Managing pyoderma gangrenosum: a synergistic approach combining surgical debridement, vacuum-assisted closure, and hyperbaric oxygen therapy. Plast Reconstr Surg 117 (2006) 24-28
5. Pastor N., Betlloch I., Pascual J.C., et al. Pyoderma gangrenosum treated with anti-TNF alpha therapy (Etanercept). Clin Exp Dermatol 31 (2005) 152-153